Illinois Bone & Joint Institute Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT00984815
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

famotidine (pepcid) (1 trial)

ibuprofen (motrin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Arthritis, Rheumatoid (Phase 3)

Back Pain (Phase 3)

Low Back Pain (Phase 3)

Nociceptive Pain (Phase 3)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2